$DSS
DSS, INC. Stock $dss

$dss Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223010334 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$11.93M	$11.38M	$47.31M
YoY Change	-3.07%	61.26%	133.33%
Cost Of Revenue	$8.533M	$9.810M	$37.46M
YoY Change	56.77%	255.69%	205.3%
Gross Profit	$3.393M	$1.570M	$9.844M
YoY Change	-50.55%	-63.48%	22.99%
Gross Profit Margin	28.45%	13.8%	20.81%
Selling, General & Admin	$8.973M	$11.05M	$53.53M
YoY Change	-6.24%	67.9%	138.95%
% of Gross Profit	264.46%	703.57%	543.79%
Research & Development	$179.0K	$551.0K	$1.256M
YoY Change	6.55%	26.67%	16.3%
% of Gross Profit	5.28%	35.1%	12.76%
Depreciation & Amortization	$1.333M	$3.574M	$12.93M
YoY Change	-59.19%	59.06%	199.05%
% of Gross Profit	39.29%	227.64%	131.3%
Operating Expenses	$17.51M	$13.22M	$90.99M
YoY Change	28.68%	36.0%	209.37%
Operating Profit	-$5.580M	-$11.65M	-$43.69M
YoY Change	-17.25%	114.93%	104.06%
Interest Expense	$249.0K	-$853.0K	$2.910M
YoY Change	-127.36%	-88.05%	-116.52%
% of Operating Profit
Other Income/Expense, Net	-$65.00K	-$601.0K	$3.602M
YoY Change	-96.18%	-340.4%	336.61%
Pretax Income	-$8.633M	-$30.33M	-$69.49M
YoY Change	-3.55%	146.48%	82.47%
Income Tax		$172.0K	$172.0K
% Of Pretax Income
Net Earnings	-$8.035M	-$26.93M	-$59.84M
YoY Change	-0.16%	124.33%	93.03%
Net Earnings / Revenue	-67.37%	-236.61%	-126.49%
Basic Earnings Per Share	-$0.06		-$0.54
Diluted Earnings Per Share	-$0.06	-$0.19	-$0.54
COMMON SHARES
Basic Shares Outstanding	139.0M shares	139.0M shares	111.6M shares
Diluted Shares Outstanding	139.0M shares		111.6M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.73M	$46.59M	$19.29M
YoY Change	-74.48%	-17.68%	-65.92%
Cash & Equivalents	$13.70M	$19.29M
Short-Term Investments		$27.30M
Other Short-Term Assets	$2.043M	$1.700M	$1.700M
YoY Change	9.31%	-50.95%	-50.95%
Inventory	$7.262M	$7.721M	$7.721M
Prepaid Expenses
Receivables	$6.995M	$7.564M	$7.564M
Other Receivables	$11.42M	$11.72M	$11.72M
Total Short-Term Assets	$41.45M	$47.99M	$47.99M
YoY Change	-47.06%	-41.77%	-41.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.61M	$13.39M	$76.64M
YoY Change	-81.56%	-82.04%	2.81%
Goodwill	$60.92M	$60.92M
YoY Change		7.62%
Intangibles
YoY Change
Long-Term Investments	$157.0K	$162.0K	$29.00M
YoY Change	-99.48%	-99.38%	10.47%
Other Assets	$2.754M	$2.699M	$2.699M
YoY Change	394.43%	451.94%	451.94%
Total Long-Term Assets	$185.3M	$200.9M	$200.9M
YoY Change	-8.97%	-0.73%	-0.73%
TOTAL ASSETS
Total Short-Term Assets	$41.45M	$47.99M	$47.99M
Total Long-Term Assets	$185.3M	$200.9M	$200.9M
Total Assets	$226.8M	$248.9M	$248.9M
YoY Change	-19.55%	-12.61%	-12.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.095M	$5.914M	$5.914M
YoY Change	107.79%	208.02%	208.02%
Accrued Expenses	$10.26M	$20.14M	$19.26M
YoY Change	-39.84%	-6.66%	-4.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$48.77M	$47.16M	$47.16M
YoY Change	613.58%	1104.32%	1104.32%
Total Short-Term Liabilities	$64.61M	$73.69M	$73.69M
YoY Change	141.57%	164.96%	164.96%
LONG-TERM LIABILITIES
Long-Term Debt	$5.778M	$10.18M	$10.18M
YoY Change	-90.27%	-81.73%	-81.73%
Other Long-Term Liabilities	$507.0K	$507.0K	$8.327M
YoY Change	-69.49%	-49.3%	732.7%
Total Long-Term Liabilities	$6.285M	$10.69M	$18.51M
YoY Change	-89.71%	-81.15%	-67.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$64.61M	$73.69M	$73.69M
Total Long-Term Liabilities	$6.285M	$10.69M	$18.51M
Total Liabilities	$70.89M	$84.38M	$123.4M
YoY Change	-42.9%	-30.23%	2.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$202.4M	-$194.3M
YoY Change		44.49%
Common Stock	$2.779M	$2.779M
YoY Change		74.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$117.5M	$125.6M	$125.6M
YoY Change
Total Liabilities & Shareholders Equity	$226.8M	$248.9M	$248.9M
YoY Change	-19.55%	-12.61%	-12.61%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$8.035M	-$26.93M	-$59.84M
YoY Change	-0.16%	124.33%	93.03%
Depreciation, Depletion And Amortization	$1.333M	$3.574M	$12.93M
YoY Change	-59.19%	59.06%	199.05%
Cash From Operating Activities	-$14.20M	-$3.702M	-$26.95M
YoY Change	133.92%	-207.74%	206.11%
INVESTING ACTIVITIES
Capital Expenditures	$594.0K	$1.273M	$2.294M
YoY Change	-163.06%	-104.47%	-107.08%
Acquisitions			$1.879M
YoY Change			-155.99%
Other Investing Activities	$12.13M	$1.120M	-$15.17M
YoY Change	-374.64%	-102.78%	-82.49%
Cash From Investing Activities	$11.54M	-$153.0K	-$17.97M
YoY Change	-315.28%	-99.78%	-84.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.519M
YoY Change			-98.75%
Debt Paid & Issued, Net	$4.002M		$3.504M
YoY Change	1526.83%		79.69%
Cash From Financing Activities	-$2.896M	300.0K	$7.617M
YoY Change	-133.5%	-99.43%	-95.75%
NET CHANGE
Cash From Operating Activities	-$14.20M	-3.702M	-$26.95M
Cash From Investing Activities	$11.54M	-153.0K	-$17.97M
Cash From Financing Activities	-$2.896M	300.0K	$7.617M
Net Change In Cash	-$5.558M	-3.555M	-$37.31M
YoY Change	99.64%	-72.42%	-172.56%
FREE CASH FLOW
Cash From Operating Activities	-$14.20M	-$3.702M	-$26.95M
Capital Expenditures	$594.0K	$1.273M	$2.294M
Free Cash Flow	-$14.79M	-$4.975M	-$29.25M
YoY Change	188.48%	-115.6%	-223.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000771999
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments		usd
CY2021	DSS	Impairment Of Fixed Asset ImpairmentOfFixedAsset		usd
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
CY2021	DSS	Change In Rightof Use Assets ChangeInRightofUseAssets		usd
CY2021	DSS	Change In Rightof Use Liabilities ChangeInRightofUseLiabilities		usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	DSS	Impairment Of Notes Receivable And Other Investments ImpairmentOfNotesReceivableAndOtherInvestments		usd
CY2021	DSS	Impairment Of Other Investments ImpairmentOfOtherInvestments		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2021	DSS	Payment For Change In Equity Investment PaymentForChangeInEquityInvestment		usd
CY2021	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable		usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022	DSS	Cash Provided By Used In Operating Activities Discontinued Operation CashProvidedByUsedInOperatingActivitiesDiscontinuedOperation		usd
CY2022	DSS	Cash Provided By Used In Investing Activities Discontinued Operation CashProvidedByUsedInInvestingActivitiesDiscontinuedOperation		usd
CY2022	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations		usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent		usd
CY2021Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	DSS	Income Tax Effect Of Discontinued Operations IncomeTaxEffectOfDiscontinuedOperations		usd
CY2021Q4	DSS	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021	DSS	Effective Income Tax Rate Reconciliation Permanent Difference EffectiveIncomeTaxRateReconciliationPermanentDifference		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0093	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential		pure
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	DSS	Termination Of Right Of Use Lease Asset TerminationOfRightOfUseLeaseAsset		usd
CY2022	DSS	Termination Of Right Of Use Lease Liability TerminationOfRightOfUseLeaseLiability		usd
CY2022	DSS	Shares Received For Loan Origination Fee SharesReceivedForLoanOriginationFee		usd
CY2022	DSS	Shares Received For Prepaid Loan Interest SharesReceivedForPrepaidLoanInterest		usd
CY2021	DSS	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets		usd
CY2022	DSS	Acquisition Of Net Assets AcquisitionOfNetAssets		usd
CY2021	DSS	Shares Issued In Lieu Of Bonus Cash SharesIssuedInLieuOfBonusCash		usd
CY2021	DSS	Notes Receivable Conversion To Equity NotesReceivableConversionToEquity		usd
CY2021	DSS	Right Of Use Asset Addition RightOfUseAssetAddition		usd
CY2021	DSS	Revenue On Commission Income RevenueOnCommissionIncome		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-32146
CY2022	dei	Entity Registrant Name EntityRegistrantName	DSS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-1229730
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	275 Wiregrass Pkwy
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Henrietta
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14586
CY2022	dei	City Area Code CityAreaCode	(585)
CY2022	dei	Local Phone Number LocalPhoneNumber	325-3610
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.02 per share
CY2022	dei	Trading Symbol TradingSymbol	DSS
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	20031316	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	139017172	shares
CY2022	dei	Auditor Firm AuditorFirmId	76
CY2022	dei	Auditor Name AuditorName	Turner Stone & Company, LLP
CY2022	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19290000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27811000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10181000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	55711000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7820000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	880000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56595000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7564000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5673000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	8261000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	11719000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	6310000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1700000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3466000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	47994000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	80305000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13391000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17674000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	55029000	usd
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	56374000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	1534000	usd
CY2021Q4	us-gaap	Other Investments OtherInvestments	11001000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	162000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1080000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	27307000	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	14172000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	922000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	5878000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2699000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	489000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8219000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	498000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	60919000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	56606000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	30740000	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	38630000	usd
CY2022Q4	us-gaap	Assets Assets	248916000	usd
CY2021Q4	us-gaap	Assets Assets	282707000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5914000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1920000	usd
CY2022Q4	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	19341000	usd
CY2021Q4	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	21180000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	447000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	402000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	796000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	393000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	47161000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3916000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73689000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	47000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	47000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139017172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139017172	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79745886	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79745886	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2779000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1594000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317126000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	294685000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194343000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-134503000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125562000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161776000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	31119000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	36409000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	248916000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	282707000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47307000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20275000	usd
CY2022	DSS	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	37463000	usd
CY2021	DSS	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	16824000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	53531000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26979000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	90994000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	43803000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-43687000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-23528000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	629000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	4556000	usd
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	159000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3602000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	825000	usd
CY2022	us-gaap	Interest Expense InterestExpense	2910000	usd
CY2021	us-gaap	Interest Expense InterestExpense	196000	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-8750000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	116000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	129000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9936000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-10697000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-12035000	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	5637000	usd
CY2022	DSS	Impairment Of Fixed Asset ImpairmentOfFixedAsset	2843000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	405000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-69490000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40201000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4032000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-69662000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-36169000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	2129000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-69662000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-34040000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9822000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-921000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59840000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-33119000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.04
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.04
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	111622114	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51525746	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	111622114	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51525746	shares
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-69662000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-36169000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12925000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4322000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	78000	usd
CY2022	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	129000	usd
CY2021	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	-9939000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-13386000	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-12035000	usd
CY2022	DSS	Change In Rightof Use Assets ChangeInRightofUseAssets	7721000	usd
CY2022	DSS	Change In Rightof Use Liabilities ChangeInRightofUseLiabilities	8103000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	116000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	38000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4032000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2843000	usd
CY2022	DSS	Impairment Of Notes Receivable And Other Investments ImpairmentOfNotesReceivableAndOtherInvestments	1525000	usd
CY2022	DSS	Impairment Of Other Investments ImpairmentOfOtherInvestments	5637000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1891000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2084000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-540000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6306000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1766000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2274000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2210000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1216000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3994000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	463000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4307000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	15920000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-298000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2004000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26953000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9012000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2294000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14283000	usd
CY2022	DSS	Payments To Acquire Real Estates PaymentsToAcquireRealEstates	732000	usd
CY2021	DSS	Payments To Acquire Real Estates PaymentsToAcquireRealEstates	56794000	usd
CY2022	DSS	Payments For Proceeds From Investments Excluding Notes Receivables PaymentsForProceedsFromInvestmentsExcludingNotesReceivables	195000	usd
CY2021	DSS	Payments For Proceeds From Investments Excluding Notes Receivables PaymentsForProceedsFromInvestmentsExcludingNotesReceivables	4130000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14884000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8171000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2152000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1879000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-3356000	usd
CY2022	DSS	Conversion Of Shrg To Consolidation ConversionOfShrgToConsolidation	3038000	usd
CY2021	DSS	Conversion Of Shrg To Consolidation ConversionOfShrgToConsolidation	-12225000	usd
CY2022	DSS	Payment For Change In Equity Investment PaymentForChangeInEquityInvestment	113000	usd
CY2022	DSS	Payments To Acquire Note Receivable Investments PaymentsToAcquireNoteReceivableInvestments	3621000	usd
CY2021	DSS	Payments To Acquire Note Receivable Investments PaymentsToAcquireNoteReceivableInvestments	11651000	usd
CY2022	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	1067000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	508000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	18110000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17969000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-122008000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3504000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1950000	usd
CY2022	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	9602000	usd
CY2021	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	60864000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1425000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1519000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	121736000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7617000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	179225000	usd
CY2021	DSS	Cash Provided By Used In Operating Activities Discontinued Operation CashProvidedByUsedInOperatingActivitiesDiscontinuedOperation	207000	usd
CY2021	DSS	Cash Provided By Used In Investing Activities Discontinued Operation CashProvidedByUsedInInvestingActivitiesDiscontinuedOperation	3000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	3207000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37305000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	51412000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56595000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5183000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19290000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56595000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17405000	usd
CY2022	DSS	Stock Issued During Period Value Acquisition StockIssuedDuringPeriodValueAcquisition	1274000	usd
CY2022	DSS	Adjustments To Additional Paid In Capital Acquisition Of Sharing Services Global Corporation AdjustmentsToAdditionalPaidInCapitalAcquisitionOfSharingServicesGlobalCorporation	3257000	usd
CY2022	DSS	Stock Issued During Period Value Stock Based Payments StockIssuedDuringPeriodValueStockBasedPayments	6221000	usd
CY2022	DSS	Net Loss NetLoss	-69661000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76545000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76545000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	121780000	usd
CY2021	DSS	Stock Issued During Period Value Stock Based Payments StockIssuedDuringPeriodValueStockBasedPayments	2000	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	33097000	usd
CY2021	DSS	Stock Issued During Period Value Acquisitions One StockIssuedDuringPeriodValueAcquisitionsOne	803000	usd
CY2021	DSS	Net Loss NetLoss	-34040000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zZYKNAMuzA4l" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zeaxJOSbyQde">Use of Estimates</span> </i></b>– The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, the Company evaluates its estimates, including those related to the accounts receivable, convertible notes receivable, inventory, fair values of investments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of options and warrants to purchase the Company’s common stock, preferred stock, deferred revenue, and income taxes, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ztfROxTHiHB4" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_z58gkopNj6cc">Reclassifications</span> </i></b>– Certain amounts on the accompanying consolidated balance sheets and income statements for the year ended December 31, 2021, have been reclassified to conform to current period presentation, as have certain amounts for the year ended, December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	20000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	388000	usd
CY2022Q4	DSS	Sales Commissions Capitalized SalesCommissionsCapitalized	0	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1256000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1080000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zohaH7ro02B6" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zu0oINwJuFjk">Concentration of Credit Risk</span></i></b> - The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk because of any non-performance by the financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, two customers accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMumyZQ3OJyl">27</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxGtibCl2UD">14</span>% of our consolidated revenue and these two customers accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zISQN6Te7O5b">29</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFNSb3J59imd">19</span>% of our consolidated trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">As of December 31, 2022, two customers accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzGOZgYFUFU8">14% </span>and 6% of our consolidated revenue and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zidFDsww3mYk">36</span>% and 17% of our trade accounts receivable balance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q2	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	1	pure
CY2022Q4	us-gaap	Cash Cash	19300000	usd
CY2022Q4	us-gaap	Cash Cash	19300000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	27300000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	11200000	usd
CY2022Q4	us-gaap	Cash Cash	19300000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	27300000	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	11200000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6779000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7745000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	403000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	512000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1281000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	392000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	8463000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	8649000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	388000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	8261000	usd
CY2022Q4	DSS	Reserve On Notes ReserveOnNotes	896000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	59894000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3659000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	46776000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	19290000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	27307000	usd
CY2022Q4	us-gaap	Investments Investments	179000	usd
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	73929000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1554000	usd
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	75473000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	56595000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	14537000	usd
CY2021Q4	us-gaap	Investments Investments	4341000	usd
CY2022	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	96000	usd
CY2022Q4	us-gaap	Business Combination Acquired Receivables Fair Value BusinessCombinationAcquiredReceivablesFairValue	34260000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	49076804	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	21144	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-61680088	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-36202377	usd
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.55
CY2021	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.70
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.55
CY2021	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.70
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17578000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24128000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4187000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6454000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13391000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17674000	usd
CY2022	us-gaap	Depreciation Depreciation	1569000	usd
CY2021	us-gaap	Depreciation Depreciation	1129000	usd
CY2022	us-gaap	Depreciation Depreciation	1569000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	57526000	usd
CY2021Q4	us-gaap	Real Estate Investments RealEstateInvestments	56794000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	2497000	usd
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	420000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	55029000	usd
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	56374000	usd
CY2022Q4	us-gaap	Real Estate Owned Accumulated Depreciation RealEstateOwnedAccumulatedDepreciation	2077000	usd
CY2021Q4	us-gaap	Real Estate Owned Accumulated Depreciation RealEstateOwnedAccumulatedDepreciation	420000	usd
CY2021Q2	us-gaap	Area Of Land AreaOfLand	40000	sqft
CY2021Q2	us-gaap	Area Of Land AreaOfLand	13.62	acre
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	585000	usd
CY2021Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15901000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43835000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13095000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30740000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43341000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4711000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	38630000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9279000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3279000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2421000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2146000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2353000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2025000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2368000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	188000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	160000	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	519000	usd
CY2021Q4	us-gaap	Deferred Income DeferredIncome	1348000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4014000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	11992000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1070000	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	8974000	usd
CY2021Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	342000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	926000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	922000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4535000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4024000	usd
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	172000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	12000	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	1322000	usd
CY2022Q4	DSS	Accrued Expense And Deferred Revenue Current AccruedExpenseAndDeferredRevenueCurrent	19340000	usd
CY2021Q4	DSS	Accrued Expense And Deferred Revenue Current AccruedExpenseAndDeferredRevenueCurrent	21180000	usd
CY2021Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	6155000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	46869000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3692000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	736000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	769000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	805000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	4561000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11930	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	218.39
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	19264	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	150.30
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	6930	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	344.58
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7334	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	39.85
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	43.50
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y6M14D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11930	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	218.39
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	43.50
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y6M14D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11930	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	218.39
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y2M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6597	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	199.07
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2000	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	119000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	134000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-14839000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5336000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-492000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-778000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-58000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-123000	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-15390000	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-6237000	usd
CY2022	DSS	Deferred Income Tax Expense Benefit Increase Derease In Allowance DeferredIncomeTaxExpenseBenefitIncreaseDereaseInAllowance	-15427000	usd
CY2021	DSS	Deferred Income Tax Expense Benefit Increase Derease In Allowance DeferredIncomeTaxExpenseBenefitIncreaseDereaseInAllowance	-2739000	usd
CY2022	DSS	Deferred Income Tax Net Of Discontinued Operations DeferredIncomeTaxNetOfDiscontinuedOperations	38000	usd
CY2021	DSS	Deferred Income Tax Net Of Discontinued Operations DeferredIncomeTaxNetOfDiscontinuedOperations	-3498000	usd
CY2021	DSS	Income Tax Effect Of Discontinued Operations IncomeTaxEffectOfDiscontinuedOperations	533000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4032000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24975000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14453000	usd
CY2022Q4	DSS	Deferred Tax Assets Unrealized Loss On Securities DeferredTaxAssetsUnrealizedLossOnSecurities	5753000	usd
CY2021Q4	DSS	Deferred Tax Assets Unrealized Loss On Securities DeferredTaxAssetsUnrealizedLossOnSecurities	2598000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	190000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	189000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	34000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	21000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	11000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	11000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	176000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	176000	usd
CY2022Q4	DSS	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	1935000	usd
CY2021Q4	DSS	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	47000	usd
CY2022Q4	DSS	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	24000	usd
CY2021Q4	DSS	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	5000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	696000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	620000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33794000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18120000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2822000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	4143000	usd
CY2022Q4	DSS	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	-194000	usd
CY2022Q4	DSS	Deferred Tax Liabilities Rightof Use Asset DeferredTaxLiabilitiesRightofUseAsset	1846000	usd
CY2021Q4	DSS	Deferred Tax Liabilities Rightof Use Asset DeferredTaxLiabilitiesRightofUseAsset	47000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4474000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4190000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29357000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13929000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	38000	usd
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	43800000	usd
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2900000	usd
CY2022	DSS	Net Operating Loss Carryforwards Expiration Date Descrption NetOperatingLossCarryforwardsExpirationDateDescrption	expire through 2042
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	15400000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2700000	usd
CY2022	DSS	Income Tax Reconciliation Change In Deferred Tax Liability Allowance IncomeTaxReconciliationChangeInDeferredTaxLiabilityAllowance	1400000	usd
CY2021	DSS	Income Tax Reconciliation Change In Deferred Tax Liability Allowance IncomeTaxReconciliationChangeInDeferredTaxLiabilityAllowance	2800000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0051	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013	pure
CY2022	DSS	Effective Income Tax Rate Reconciliation Permanent Difference EffectiveIncomeTaxRateReconciliationPermanentDifference	0.0003	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.011	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0007	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2266	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.077	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0025	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.098	pure
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2018Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1	pure
CY2018Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.01	pure
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	124000	usd
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	99000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	977000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	190000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1146000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	915000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	883000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	899000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	916000	usd
CY2022Q4	DSS	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	1076000	usd
CY2022Q4	DSS	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	4912000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10747000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2131000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8616000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	796000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7820000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043	pure
CY2022	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	220000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	3270000	usd
CY2021	DSS	Termination Of Right Of Use Lease Asset TerminationOfRightOfUseLeaseAsset	-744000	usd
CY2021	DSS	Termination Of Right Of Use Lease Liability TerminationOfRightOfUseLeaseLiability	744000	usd
CY2021	DSS	Shares Received For Loan Origination Fee SharesReceivedForLoanOriginationFee	-3000000	usd
CY2021	DSS	Shares Received For Prepaid Loan Interest SharesReceivedForPrepaidLoanInterest	-2440000	usd
CY2022	DSS	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	9568000	usd
CY2021	DSS	Acquisition Of Net Assets AcquisitionOfNetAssets	38765000	usd
CY2022	DSS	Shares Issued In Lieu Of Bonus Cash SharesIssuedInLieuOfBonusCash	6221000	usd
CY2022	DSS	Notes Receivable Conversion To Equity NotesReceivableConversionToEquity	8717000	usd
CY2022	DSS	Right Of Use Asset Addition RightOfUseAssetAddition	7169000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segments
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47307000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11463000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	37463000	usd
CY2022	us-gaap	Interest Expense InterestExpense	2910000	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4000	usd
CY2022	DSS	Income Loss From Continuing Operation IncomeLossFromContinuingOperation	-69664000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2294000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20275000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4236000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	16824000	usd
CY2021	us-gaap	Interest Expense InterestExpense	196000	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	46000	usd
CY2021	DSS	Income Loss From Continuing Operation IncomeLossFromContinuingOperation	-36084000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	71077000	usd
CY2022	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	17973000	usd
CY2021	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	15539000	usd
CY2022	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	21989000	usd
CY2021	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	3259000	usd
CY2022	DSS	Revenue On Securities RevenueOnSecurities	6287000	usd
CY2021	DSS	Revenue On Securities RevenueOnSecurities	1203000	usd
CY2022	DSS	Revenue On Commission Income RevenueOnCommissionIncome	294000	usd
CY2022	DSS	Revenue On Management Fees Income RevenueOnManagementFeesIncome	134000	usd
CY2021	DSS	Revenue On Management Fees Income RevenueOnManagementFeesIncome	24000	usd
CY2022	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	630000	usd
CY2021	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	250000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares

Files In Submission

Name	View Source	Status
dss-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dss-20221231_cal.xml	Edgar Link	unprocessable
0001493152-23-010334-index-headers.html	Edgar Link	pending
0001493152-23-010334-index.html	Edgar Link	pending
0001493152-23-010334.txt	Edgar Link	pending
0001493152-23-010334-xbrl.zip	Edgar Link	pending
dss-20221231.xsd	Edgar Link	pending
ex1.htm	Edgar Link	pending
ex10-18.htm	Edgar Link	pending
ex1_001.jpg	Edgar Link	pending
ex1_002.jpg	Edgar Link	pending
ex1_003.jpg	Edgar Link	pending
dss-20221231_def.xml	Edgar Link	unprocessable
dss-20221231_pre.xml	Edgar Link	unprocessable
ex1_004.jpg	Edgar Link	pending
ex1_005.jpg	Edgar Link	pending
ex1_006.jpg	Edgar Link	pending
ex1_007.jpg	Edgar Link	pending
ex1_008.jpg	Edgar Link	pending
ex1_009.jpg	Edgar Link	pending
ex1_010.jpg	Edgar Link	pending
ex1_011.jpg	Edgar Link	pending
ex1_012.jpg	Edgar Link	pending
ex1_013.jpg	Edgar Link	pending
ex1_014.jpg	Edgar Link	pending
ex1_015.jpg	Edgar Link	pending
ex1_016.jpg	Edgar Link	pending
ex1_017.jpg	Edgar Link	pending
ex1_018.jpg	Edgar Link	pending
ex1_019.jpg	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
re_001.jpg	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DSS
DSS, INC. Stock $dss

2023 Q1 Form 10-K Financial Statement

#000149315223010334 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS DSS, INC. Stock $dss

2023 Q1 Form 10-K Financial Statement

#000149315223010334 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS
DSS, INC. Stock $dss